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Background: Ciprofloxacin (CIP), moxifloxacin (MOX), norfloxacin (NOR) and ofloxacin (OFL), are the antibacterial
synthetic drugs, belonging to the fluoroquinolones group. Fluoroquinolones are compounds susceptible to
photodegradation process, which may lead to reduction of their antibacterial activity and to induce phototoxicity
as a side effect. This paper describes a simple, sensitive UPLC-MS/MS method for the determination of CIP, MOX,
NOR and OFL in the presence of photodegradation products.
Results: Chromatographic separations were carried out using the Acquity UPLC BEH C18 column; (2.1 × 100 mm,
1.7 μm particle size). The column was maintained at 40°C, and the following gradient was used: 0 min, 95% of
eluent A and 5% of eluent B; 10 min, 0% of eluent A and 100% of eluent B, at a flow rate of 0.3 mL min-1. Eluent A:
0.1% (v/v) formic acid in water; eluent B: 0.1% (v/v) formic acid in acetonitrile. The method was validated and all the
validation parameters were in the ranges acceptable by the guidelines for analytical method validation. The
photodegradation of examined fluoroquinolones in solid phase in the presence of excipients followed kinetic of the
first order reaction and depended upon the type of analyzed drugs and coexisting substances. Photodegradation
process of analyzed drugs was confirmed by differential scanning calorimetry. In addition, the identification of
degradation products was carried out by mass spectrometry.
Conclusion: The developed UPLC-MS/MS method enables the determination of CIP, MOX, NOR and OFL in the
presence of photodegradation products and identification of photodegradation products.
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Ciprofloxacin (CIP), moxifloxacin (MOX), norfloxacin
(NOR) and ofloxacin (OFL), are the antibacterial syn-
thetic drugs, belonging to fluoroquinolones group.
Fluoroquinolones exhibit increased antibacterial activity
against the Enterobacteriaceae and other Gram-negative
bacteria such as Pseudomonas aeruginosa, and exert some
activity against certain Gram-positive cocci [1,2]. Among
them, MOX also show notable efficacy against atypical* Correspondence: urszula.hubicka@uj.edu.pl
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distribution, and reproduction in any mediumbacteria of Chlamydia spp., Mycoplasma spp., and Legion-
ella spp. genera, bacilli of genus Mycobacterium and an-
aerobe of Bacteroides and Clostridium genera [3-5].
Fluoroquinolones are compounds susceptible to photo-
degradation process, which may lead to reduction of their
antibacterial activity and to induce phototoxicity as a side
effect [6]. In the available literature many papers devoted
to the studies of fluoroquinolone photodegradation in so-
lutions can be found [7-10], while only a few relate to
photodegradation studies of a substance or of the pharma-
ceutical preparation in the solid phase [10-13].
The photodegradation process of CIP in solid phase
was analyzed by thin layer chromatography method withtral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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lected metal ions. Samples were prepared on Petri dishes
by evaporation of the test solution to obtain a dry resi-
due. They were exposed to UV radiation within the
range from 240 nm to 280 nm for 96 h [11]. Assessed
the studies performed it was found that both ion con-
centration and ion type have an effect on the degradation
process that leads to the generation of two photoproducts.
The chemical structures of the photodegradation prod-
ucts were identified as follows 7-[(2-aminoethyl)amino]
1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-qunoline-3-
carboxylic acid and 7-amino-1-cyclopropyl-6-fluoro-1,4-
dihydro-4-oxo-qunoline-3-carboxylic acid [11].
Photostability of MOX after UVA irradiation in solu-
tions and solid phase, with and without participation of
Cu(II), Zn(II), Al(III), and Fe(III) was tested. Samples for
testing in solid phase were prepared in the same manner
as described in a publication on CIP [11]. They were ex-
posed to UVA radiation within the range from 320 nm
to 400 nm for 15 h [10]. The studies were carried out by
the TLC-densitometric method. In solid phase, all metal
ions decreased the photodegradation of MOX. Identifica-
tion of the degradation three products was performed with
LC-MS/MS and 1HNMR identified them as: 1-cyclopropyl-
6-fluoro-7-amino-8-methoxy-4-oxo-1,4-dihydroquinoline-
3-carboxylic acid, 1-cyclopropyl-6-fluoro-8-methoxy-4-
oxo-7-(2-oxo-octahydro-6H-pyrrolo[3,4-b]pyridine-6-yl)-1,
4-dihydroquinoline-3-carboxylic acid, 7-[3-hydroxyamino-
4-(2-carboxyethyl)pyrrolidin-1-yl]-1- cyclopropyl-6-fluoro-8-
methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylic acid [10].
Photodegradation of NOR in solid phase in the pres-
ence of different excipients used for making tablets has
been studied. The NOR tablets were exposed under dir-
ect sunlight, fluorescent light and UV radiation (con-
tinuous 254-nm UV lamp), at ambient temperature (25°C)
and 65% relative humidity. The separation of NOR and its
degradation products was achieved isocratically using a
Lichrosorb® C8 chromatographic column (10 μm, 20 cm ×
4.6 mm) and phosphate buffer solution adjusted to
pH 3.0 – acetonitrile (85:15, v/v) as the eluent, pumped
at a flow rate of 2.0 ml/min. The authors proved that
during photodegradation diamineethyl derivative of NOR
occurs [12].
The photostability of OFL in the solid state has been
investigated. Irradiation was conducted in a chamber
SUNTEST CPS + at 30°C using xenon lamp (1.5 kW)
equipped with a 6 mm special glass filter, transmitting
light corresponding to exposure behind window-glass
(cut-off approximately 310 nm). The change in colour of
uncoated and film coated OFL tablets and compressed
OFL was studied as a function of irradiance level and
total exposure energy. The degradation of OFL was
quantified by HPLC. The separation of OFL and its two
degradation products was achieved using a Symmetry C-18chromatographic column (3,5 μm, 100 mm × 4.6 mm).
The mobile phase consisted of triethylamine (4.5 ml),
double-distilled water (830 ml) and acetonitrile (140 ml).
The pH was adjusted to 2.3 with 85% H3PO4 before
addition of acetonitrile. The flow rate was 1 ml/min. The
structure of two main degradation products of OFL has
been postulated from LC-MS analysis [13].
In summary, the existing research concerning the
photostability of fluoroquinolones in the solid phase are
not a comprehensive but relate of individual substances.
The study was performed using different irradiation con-
ditions and exposure time. Only two papers concern the
influence of excipients on the photodegradation process.
Applied methods such as TLC, HPLC and LC-MS
allowed the separation and identification of up to three
photodegradation products. In any paper not carried out
studies of fluoroquinolones irradiated in the solid phase
by DSC.
In the presented paper we have developed and vali-
dated an ultra-performance liquid chromatography
method coupled with tandem mass spectrometry
(UPLC-MS/MS) for the determination of CIP, MOX,
NOR and OFL, which was used to study the effect of
UVA irradiation on the photostability of studied
fluoroquinolones in powdered tablets. In addition, the
kinetic evaluation of the photodegradation process was
carried out and photodegradation products have been
identified. In the presented studies next to UPLC-MS
/MS method, differential scanning calorimetry (DSC)
was also used to compare changes in analyzed samples
before and after irradiation.
Experimental
Chemicals and reagents
Ciprofloxacin hydrochloride monohydrate Cat. No. 91033-
1G Fluka, Moxifloxacin hydrochloride series Strasbourg
Cedex; Council of Europe – EDQM CS; Cat No. T30026
F-6081, Norfloxacin Cat. No. 9890-1G Fluka, Ofloxacin
Cat. No. O8757-1G Sigma. HPLC grade methanol, aceto-
nitrile and formic acid (98%) were purchased from J.T.
Baker. HPLC grade water was obtained from HLP 5
(HYDROLAB Poland) apparatus and was filtered through
0.2 μm filter before use.
Standard solution
For method validation, solutions containing different con-
centrations of the examined fluoroquinolones in the range
0.04 – 2.00 mg mL-1 were prepared.
Pharmaceutical preparations
Proxacin 500 – film-coated tablet containing 500 mg
of CIP (Polfa S.A, Poland). Excipients: pregelatinized
starch, microcrystalline cellulose, colloidal silica hydrated,
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macrogol 6000, titanium dioxide.
Norflox- AZU – film-coated tablet containing 400 mg
of NOR (Azupharma, Germany). Excipients: microcrys-
talline cellulose, hypromellose, magnesium stearate, poly
(O-carboxymethyl) starch sodium salt, povidone, propyl-
ene glycol, colloidal silica anhydrous, talc, titanium
dioxide.
Avelox - film-coated tablet containing 400 mg of
MOX (Bayer, Germany). Excipients: microcrystalline cel-
lulose, croscarmellose sodium, lactose monohydrate,
magnesium stearate, hypromellose, macrogol 4000, ferric
oxide, titanium dioxide.
Zanocin - film-coated tablet containing 200 mg of OFL
(Ranbaxy, Indie). Excipients: microcrystalline cellulose,
maize starch, lactose, magnesium stearate, polysorbate 80,
talc, colloidal silica anhydrous, sodium starch glycolate,
hydroxypropylmethylcellulose, macrogol 4000, titanium
dioxide.
Irradiation conditions and preparation of samples
Irradiation was conducted in a climatic chamber KBF-ICH
240 APT.line™; (Binder GmbH, Tuttlingen, Germany) at
20°C and 60% relative humidity using UVA radiation
(320–400 nm) with maximum emission at 365 nm. The
distance of the samples to radiation source was 13 cm.
The UVA dose was determined by means of radiometer
type VLX-3 W, Vilber Lourmat, with a sensor CX-365, to
be each time of 5.09 × 10-3 J cm-2 min-1.
Powdered tablet in the amount of 50.0 mg was distrib-
uted evenly on a quartz Petri dish with a diameter of
5 cm, covered with a quartz cover and placed in the cli-
matic chamber. The samples were exposed to UVA radi-
ation from 7 to 113 days.
For each sample a dark control sample was prepared,
which was protected with aluminum foil before irradiation.
After exposure specified number of days the tablet
powder was extracted with methanol and diluted to ob-
tain a solution having a concentration of 1.00 mg mL-1.
UPLC/MS/MS analysis
The UPLC-MS/MS system consisted of a Waters
ACQUITY® UPLC® (Waters Corporation, Milford, MA,
USA) coupled to a Waters TQD mass spectrometer
(electrospray ionization mode ESI-tandem quadrupole).
Chromatographic separations were carried out using the
Acquity UPLC BEH (bridged ethyl hybrid) C18 column;
2.1 × 100 mm, and 1.7 μm particle size. The column was
maintained at 40°C. The following gradient was used:
0 min, 95% of eluent A and 5% of eluent B; 10 min, 0%
of eluent A and 100% of eluent B, at a flow rate of
0.3 mL min-1. Eluent A: 0.1%(v/v) formic acid in water;
eluent B: 0,1% (v/v) formic acid in acetonitrile. Chro-
matograms were recorded using Waters eλ PDAdetector. Compound concentration (%i) after photo-
degradation was calculated from quotient of peak area
(Ai) to the sum of all peak areas (∑A) on chromato-
grams according to formulation %i = (Ai/∑A)100 at λ =
294 nm. Spectra were analyzed in 200–700 nm range
with 1.2 nm resolution and sampling rate 20 points/s.
MS detection settings of Waters TQD mass spectrom-
eter were as follows: source temperature 150°C, desolva-
tion temperature 350°C, desolvation gas flow rate
600 L h-1, cone gas flow 100 L h-1, capillary potential
3.00 kV, cone potential 20 V. Nitrogen was used for both
nebulizing and drying gas. The data were obtained in a
scan mode ranging from 50 to 1000 m/z in time 0.5 s in-
tervals; 8 scans were summed up to get the final
spectrum. Collision activated dissociations (CAD) ana-
lyses were carried out with the energy of 30 eV, and all
the fragmentations were observed in the source. Conse-
quently, the ion spectra were obtained by scanning from
50 to 600 m/z range. Data acquisition software was
MassLynx V 4.1 (Waters).
DSC analysis
The DSC measurement were performed in an atmos-
phere of nitrogen with a flow rate of 50 mL min-1 using
EXTAR DSC 7020 apparatus (SII NanoTechnology Inc.)
equipped with DSC 7020 electric cooling unit. The
temperature calibration was done with indium and tin
(melting temperature Tm of In was 156.6°C, Tm of Sn was
231.88°C). The calibration of enthalpy change was done
with tin (melting enthalpy ΔHm of Sn was 60.46 J g
-1).
The samples of about 4.0 to 4.9 mg were correctly
weighed in an aluminum pans and sealed. Then the pans
were equilibrated at 30°C for 15 min and thereafter the
melting behavior were analyzed at heating rate of 10°C.
Validation of UPLC/MS/MS method
The described method was validated for the determin-
ation of CIP, MOX, NOR and OFL in the presence of
photodegradation products by UPLC method according
to ICH guidelines [14]. To demonstrate the specificity of
the developed UPLC method the solutions of CIP, MOX,
NOR, OFL after photodegradation were analyzed. Peak
purity test was carried out for CIP, MOX, NOR, OFL
peaks by using MS detector in stressed sample. The sys-
tem suitability parameters were defined with respect to
resolution of examined fluoroquinolones peaks using solu-
tions of CIP, MOX, NOR, OFL, after photodegradation.
The linearity for CIP, MOX, NOR, OFL was assessed by
injecting six separately prepared solutions covering the
range of 0.18 – 2.00 mg mL-1. The slope of regression line,
y-intercept, standard deviation of slope and intercept, cor-
relation coefficient, R2 value and standard error of resid-
uals of the calibration curve were calculated using the
program Statistica v. 10. Next, to determine whether the
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istical test was used. Based on the standard error of resid-
uals (Se) and the slope (a) of the calibration plots and
following the formula LOD= 3.3Se/a and LOQ= 10Se/a,
the LOD and LOQ for examined fluoroquinolones were
estimated. The repeatability of the method was checked
by a sixfold analysis of the concentration level
1.00 mg mL-1 of CIP, MOXI, NOR, OFL solutions. The
same protocol was followed for three different days to
study the intermediate precision of the proposed method.
Different analysts prepared different solutions on different
days. The RSD (%) of the peak area of examined
fluoroquinolones was calculated. To demonstrate the ro-
bustness of the method deliberate small changes of flow
rate, content of acetonitrile and column temperature were
made around the optimal values. The mobile phase flow
rate was 0.30 mL min-1; to study the effect of the flow rate
on resolution, the flow rate was changed to 0.27 and
0.33 mL min-1. The effect of the column temperature was
studied at 36°C and 44°C (instead of 40°C).
Results and discussion
Photochemical reactivity of pharmaceutical substances is
important in drug formulation technology. Undesirable
changes in the pharmaceutical products induced by
UV–VIS irradiation may occur not only during the pro-
duction of active pharmaceutical ingredient (API), but
also during the preparation of dosage form or during
storage [15-17]. Literature data indicate that the stability
of pharmaceutical substances also depends on theTable 1 Validation of the method
Parameter CIP
RT (min)a 2.52 ± 0.05
Resolutiona,b 1.50
LOD (mg mL-1) 0.06
LOQ (mg mL-1) 0.18
Linear range (mg mL-1) 0.18 – 2.00
Regression equation (y):
Slope (a ± Sa) 139288.9 ± 1140.1 286
Intercept (b ± Sb) −635.2 ± 1176.9 44
t = b/Sb 0.54 < tα,f statistically
insignificant
1.66 <
in
Normality of residualsc
(Shapiro-Wilk test)
0.9343 (p = 0.49) 0.9
Correlation coefficient 0.9997
R2 value 0.9994
Precision (% RSD) 1.04
Intermediate precision (% RSD) 1.30
Regression equation y = ac + b; c - concentration of solution; y- peak area; Sa – stan
of Student’s t-test, tα,f =2.776 critical value of Student’s t-test for degrees of freedom
aMean ± SD (n = 6).
bResolutions were calculated between two adjacent peaks.
c normal distribution of residuals if p > 0.05.application of appropriate excipients [12]. Drug forms
are designed by manufacturers to maintain the quality of
pharmaceuticals under the storage conditions. However,
the tablets are sometimes pulverized to powders in clin-
ical use to make them easy to ingest for elderly or dis-
abled persons if they cannot be consumed in their whole
form [18].
The current guidelines of the International Conference
on Harmonization (ICH) require the development of
stability-indicating assay methods suitable for the deter-
mination of drugs [14].
Method validation
Herein we developed a universal UPLC-MS/MS stability-
indicating method for the separation, identification and
determination of examined fluoroquinolones in the pres-
ence of its photodegradation products. The method was
used for the kinetic studies of CIP, MOX, NOR and OFL.
The developed UPLC method was specific to examine
fluoroquinolones and guaranteed obtaining well shaped
peaks both for active substances and coexisting
photodegradation products. Peaks of main components
were quite well resolved from photodegradation prod-
ucts in chromatograms and no interference that could
have an influence on the obtained results was possible
(Table 1). The main peak purity was examined with MS
spectra using CODA algorithm (Waters Corporation,
Milford, MA, USA). The investigated MS spectra uniquely
contained signals corresponding to the examined
fluoroquinolones and solvent. Satisfactory resolution wasMOX NOR OFL
3.22 ± 0.05 2.44 ± 0.05 2.47 ± 0.04
0.92 1.51 0.80
0.06 0.09 0.10
0.18 0.26 0.30
0.18 – 1.50 0.26 – 2.00 0.30 – 1.50
408.6 ± 3181.1 166591.5 ± 2043.2 284748.3 ± 5341.4
74.6 ± 2691.5 −228.6 ± 2067.2 4043.2 ± 4455.5
tα,f statistically
significant
0.11 < tα,f statistically
insignificant
0.91 < tα,f statistically
insignificant
619 (p = 0.81) 0.9387 (p = 0.54) 0.9462 (p = 0.62)
0.9995 0.9994 0.9986
0.9989 0.9986 0.9968
0.74 1.09 0.64
0.99 1.18 0.80
dard deviation of slope;Sb - standard deviation of intercept, t- calculated value
f = 4 and significance level α = 0.05;
Figure 1 UPLC chromatograms registered for fluoroquinolones after photodegradation in solid phase in the presence of excipients:
A – CIP RT = 2.53, B – MOX RT = 3.26, C – NOR RT = 2.45, D – OFL RT = 2.50.
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Figure 2 The ln c = f(t) graph of photodegradation of CIP, MOX, NOR and OFL.
Table 2 The kinetic results of photodegradation
Component k [days-1] t0.1 [days] t0.5 [days] Correlation
coefficient r
CIP 0.9× 10-3 117.00 770.00 0.9721
MOX 2.2× 10-3 47.86 315.00 0.9936
NOR 0.7× 10-3 150.43 990.00 0.9330
OFL 0.9×10-3 117.00 770.00 0.9619
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pearing in chromatograms were sufficiently well resolved
and could be analyzed by mass spectrometry (Figure 1).
Regression analysis results obtained for examined
fluoroquinolones are presented in Table 1. The correlation
coefficients (R) and determination coefficients (R2)
obtained for linear model for all examined fluoroqui-
nolones were greater than 0.999. The y-intercepts of the
linear equation for CIP, MOX, NOR and OFL were statis-
tically insignificant. The distribution of the residuals can
well be approximated with a normal distribution as it is
shown by p-values (p > 0.05) of the Shapiro-Wilk
normality test. Based on regression analysis, it was as-
sumed that the calibration data fitted well to linear model.
Linearity range was observed in the wide concentration
range 0.18–2.00 mg mL-1 for CIP, 0.18 – 1.50 mg mL-1
for MOX, 0.26 – 2.00 mg mL-1 for NOR and 0.30-
1.50 mg mL-1 for OFL.
Sensitivity of the method was good. The LOD and LOQ
values were found to be from 0.060 to 0.10 mg mL-1 and
from 0.18 to 0.30 mg mL-1, respectively. Good precision
and intermediate precision with %RSD less than 2.0% was
observed. Detailed results were presented in Table 1. In all
the deliberately varied chromatographic conditions (flow
rate, column temperature), examined fluoroquinolones
and degradation products were adequately resolved, and
the order of elution remained unchanged.
Photodegradation of examined fluoroquinolones in
presence of excipients
The stability of the dosage form is different than API
occurring separately, and therefore the stability studies
for both forms are justified. In the case of tablets,pharmaceutical product contains additives that may
affect the stability of the drug by speeding up or slowing
down the degradation process.
In the available literature, only a few papers presenting
the problem of photodegradation of the active ingredi-
ents in the presence of excipients in the solid phase are
known [12]. Studies of the effect of UVA irradiation on
the CIP, MOX, NOR and OFL in the solid phase in the
presence of excipients from the tablets have shown that
analyzed substances undergo photodegradation and dif-
ferences occurring in the chromatograms concern only
the number of peaks, peak area and RT values. However,
no changes in the dark control samples were observed.
Photodegradation of CIP and OFL leads to formation
of six photodegradation products CP-1 - CP-6 and OP-1 -
OP-6, (Figure 1A and D), whereas in the case of NOR five
photodegradation products were identified NP-1 - NP-5
(Figure 1C ). Peak areas of individual products increase
with increasing exposure time. Photodegradation of MOX
is significantly different compared with CIP, NOR and
OFL because different number of decomposition products
MP-1 and MP-10 (Figure 1B) appears during degradation
process. Percentage amount of active substances in chro-
matograms also changes in a different way.
Table 3 Products of photodegradation of CIP
Product
Id
RT [M+H]+ Proposed structure
CP-1 2.12 330.1
CP-2 2.25 378.1
CP-3 2.37 348.1
CIP 2.53 332.1
CP-4 2.70 362.1
CP-5 3.49 291.1
Table 3 Products of photodegradation of CIP (Continued)
CP-6 3.64 263.1
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NOR 10.18% after 113 days of exposure, and for MOX
21.56% after 105 days of exposure.
Comparing the excipients present in the tested
pharmaceutical preparation some certain similarities and
differences regarding the inorganic components, which
may be involved in the photodegradation process can be
observed. The presence of TiO2 in the tablet mass in all
tested pharmaceutical preparations and the presence of
Fe2O3 in MOX pharmaceutical preparation is interesting
from the photochemical point of view.
Titanium dioxide is one of the compounds having the
ability to process the photon energy into chemical en-
ergy [19] and the Fe (III) ions, which may undergo an ir-
reversible reduction during irradiation are considered as
photosensitizers in photochemical reactions [20,21].
In the available literature manuscripts describing the
increase in the efficiency of photo-degradation under the
influence of the photocatalytic system TiO2/Fe (III) salt
in comparison with the action of these compounds
present separately are known [22,23].
The effect of Fe2O3 and TiO2 present in the MOX
tablet mass on the acceleration of photodegradation
compared to other fluoroquinolones in which there is
only TiO2 can not therefore be excluded. The observed
differences in photodegradation process may also be
dependent on the chemical structure of individual
fluoroquinolones.Kinetic evaluation
The analysis of the equation ln c = f(t) for the photo-
degradation of CIP, MOX, NOR and OFL revealed that
the process followed the kinetics of first order reaction
(Figure 2).
Depending on the type of fluoroquinolone, distribution
of the obtained results was observed (correlation coeffi-
cient R was from 0.9530 to 0.9936), which may be due
to the presence of excipients that may reduce the inten-
sity of radiation absorbed by the tested compounds.
The calculated reaction rate constants k take different
values from the smallest for NOR, higher for CIP and
OFL to the largest for MOX. Visible differences in
Table 4 Products of photodegradation of MOX
Product
Id
RT [M+H]+ Proposed structure
MP-1 1.93 252.1
MP-2 2.33 432.1
MP-3 2.43 416.1
MP-4 2.53 418.1
MP-5 2.62 365.1
MP-6 2.72 418.1
Table 4 Products of photodegradation of MOX (Continued)
MP-7 2.88 442.1
MP-8 2.93 416.1
MP-9 3.12 418.1
MOX 3.26 402.1
MP-10 4.10 293.1
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by t0.1 and t0.5 values (Table 2).
Analyzing the photodegradation results for CIP, MOX,
NOR and OFL in the powdered tablets it can be as-
sumed that the tablets containing NOR will be the least
susceptible to photodegradation process comparing to
Table 5 Products of photodegradation of NOR
Product
Id
RT [M + H]+ Proposed structure
NP-1 2.28 294.1
NOR 2.45 320.1
NP-2 3.35 279.1
NP-3 3.47 251.1
NP-4 3.58 363.1
NP-5 3.92 348.1
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photostable than tablets with MOX.
Identification of photodegradation products
The identification of photoproducts of four fluoro-
quinolones (CIP, MOX, NOR, OFL) was performed on a
basis of UPLC/MS analysis. Photodegradation products
of fluoroquinolones are shown in Tables 3, 4, 5 and 6,
for CIP, MOX, NOR, and OFL, respectively.
The photodegradation process was found mainly to
affect 7-amine substituent, while the fluoroquinolone
core remained unchanged. The only exception was
MOX, which formed product of decarboxylation and
partial reduction of dihydropiridine ring (MP-1).
Generally, the photodegradation proceeded with ring
opening and dealkylation of 7-amine substituent of the in-
vestigated fluoroquinolones or hydroxylation in the close
vicinity to nitrogen atoms in the substituent in the 7 pos-
ition of the fluoroquinolones, successive oxidation to their
oxo counterparts and subsequently opening the ring of
the substituent.
The most abundant products were products of ring
opening and dealkylation in the substituent in the 7 pos-
ition, containing amine moiety (CP-6, MP-10, NP-3, OP-4)
and their ethyl derivatives (CP-5, NP-2, OP-2). In case of
NOR 2-aminoethyl derivative (NP-1) was also observed.
Less abundant products of the photodegradation of
the fluoroquinolones were products of hydroxylation
and subsequent oxidation in the close vicinity of nitro-
gen atoms of the substituent in the 7 position, con-
taining one hydroxyl moiety (CP-3, MP-4, MP-6, MP-9,
OP-1), their oxo counterparts (MP-3, MP-8 and OP-5),
hydroxylactam moiety (CP-4, MP-2, OP-3) or multiple
carbonyl groups (MP-7, NP-5).
Other routs of photodegradation led to degradation
products with double bond on nitrogen in the substitu-
ent in the 7 position (CP-1), or containing partially de-
graded oxidized ring of that substituent (CP-2, MP-5,
NP-4, OP-6).
Differential Scanning Calorimetry
The sample of powdered CIP tablets exposed to UVA
shows a number of similarities and differences in com-
parison to the sample not exposed (Figure 3A). In the
temperature range of 104-174°C a broad endotherm, as-
sociated with the dehydration process, is observed [24]
while there is no endothermic transition at Tmax = 238.0°C
[25]. Moreover, there are two small endothermic peaks at
Tmax = 179.5°C and Tmax = 205.5°C coming from the melting
processes of the newly created chemical compounds. Endo-
thermic peak of simultaneous melting and decomposition
process has a smaller value of enthalpy ΔH= 12.8 mJ mg-1
and has been moved toward lower temperatures of Tmax =
299.5°C and Tmax = 302.1°C.
Table 6 Products of photodegradation of OFL
Product
Id
RT [M + H]+ Proposed structure
OFL 2.50 362.1
OP-1 2.81 378.1
OP-2 3.07 307.1
OP-3 3.38 392.1
OP-4 3.64 279.1
OP-5 3.97 376.1
Table 6 Products of photodegradation of OFL (Continued)
OP-6 5.32 309.1
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http://journal.chemistrycentral.com/content/7/1/133The DSC curves of powdered NOR tablets, before and
after UVA irradiation (Figure 3B), show a significant
temperature Tonset and Tmax shifts and a reductions of
the corresponding values of enthalpy ΔH. The maximum
temperature of endothermic peak corresponding to the
maximum of the first stage of decomposition [26] was
moved to 126.0°C and the enthalpy decreased to ΔH=
179.0 mJ mg-1. The next endothermic peak, describing
the melting process Tonset = 220.3°C [27], was also
changed. The value of enthalpy ΔH decreased to
21.6 mJ mg-1 and the melting temperatures Tonset and
Tmax are 191.5°C and 206.7°C respectively. The endo-
and exothermic peaks located at the end of the DSC
curves show different shapes. The exothermic peak
presented in the not irradiated sample at Tmax = 151.6°C
was not found.
The DSC curve of MOX powdered tablets exposed to
UVA shows the broadest changes compared to the cor-
responding not exposed sample (Figure 3C). One can
see the absence of the last melting peak [28] at Tonset =
231.2°C and a rapid growth of a jagged baseline with tiny
spikes. This observations suggest that the decomposition
of the sample starts much earlier. Endothermic transi-
tions at Tmax 209.1°C and 170.6°C was moved toward
lower values 198.6°C and 161.3°C. The enthalpies de-
creased as well. The peak at Tmax = 146.1°C remains un-
changed both for the temperature Tonset and ΔH values.
Particularly noteworthy is a small endothermic process
that occurs in the Tmax = 120.9°C, which is probably re-
lated to the decomposition of the sample.
In contrast to the MOX, NOR and CIP the OFL com-
pound seems to be more thermally stable and its decom-
position, associated with weight loss, starts just after
reaching the melting point T = 264.8°C [29]. The DSC
curves obtained for powdered UVA irradiated and not
irradiated tablets are not corresponding to each other
(Figure 3D). While there is no endothermic melting peak
at Tonset = 266.2°C, the new, small one at Tmax = 138.0°C
is observed. This peak could be considered as a degrad-
ation product. The peak at temperature of Tonset = 180.1°C
and ΔH= 28.2 and mJ mg-1, under the influence of UVA
Figure 3 The DSC curves of the examined fluoroquinolones; dotted line: before exposure and continuous line: after exposure to UVA;
A – CIP, B – MOX, C – NOR, D – OFL.
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http://journal.chemistrycentral.com/content/7/1/133light, significantly reduced the value of enthalpy to ΔH=
9.54 mJ mg-1 (Figure 3D).
Summing up these part of studies, one can see that
DSC curves obtained for samples exposed to UVA light
differ significantly from those not exposed. The broadest
changes, comparing to the CIP, NOR and OFL,
concerned the MOX, what confirms the results obtained
by UPLC-MS/MS method.
Conclusions
The developed UPLC-MS/MS method enables the deter-
mination of CIP, MOX, NOR and OFL in the presence
of photodegradation products and identification of
photodegradation products. The method meets the ac-
ceptance criteria for validation which guarantees correct
analysis results. It has been shown that the tested
fluoroquinolones occurring in the presence of excipients
undergo photodegradation under the influence of UVA
radiation. Photodegradation follows the kinetics of a first
order reaction. The results obtained by UPLC-MS/MS
and the calculated kinetic parameters k and t0.1 and t0.5
have shown that photodegradation of MOX is faster
than CIP, NOR and OFL. Greater susceptibility of MOX
to photodegradation process has also been shown byDSC method. It seems that the differences obtained dur-
ing the photodegradation of tested fluoroquinolones
may be connected with the presence of inorganic com-
ponents in the tablet powder such as Fe2O3 and TiO2.Abbreviations
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